Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadri Altundag

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Journal of Cancer Research and Therapeutics|October 12, 2019
Favorable results of patients with pT1a, b, c, lymph node-negative early breast cancer in the long intervalNilufer Bulut, Arife Ulas, Kadri Altundag
Expert Opinion on Pharmacotherapy|March 30, 2010
Systemic treatment in breast-cancer patients with brain metastasisCagatay Arslan, Omer Dizdar, Kadri Altundag
Expert Opinion on Pharmacotherapy|October 21, 2015
Advances in PARP inhibitors for the treatment of breast cancerOmer Dizdar, Cagatay Arslan, Kadri Altundag
Expert Opinion on Pharmacotherapy|July 18, 2014
Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an updateCagatay Arslan, Omer Dizdar, Kadri Altundag
Expert Opinion on Pharmacotherapy|October 28, 2010
The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectivesOnder Tonyali, Cagatay Arslan, Kadri Altundag
Expert Opinion on Pharmacotherapy|July 31, 2009
Pharmacotherapy of triple-negative breast cancerCagatay Arslan, Omer Dizdar, Kadri Altundag
Medical Oncology (Northwood, London, England)|April 23, 2013
The significance of heat shock proteins in breast cancer therapySevil Oskay Halacli, Burcin Halacli, Kadri Altundag
Current Medicinal Chemistry. Anti-Cancer Agents|March 22, 2005
Monoclonal antibody-based targeted therapy in breast cancerKadri Altundag, Francisco J Esteva, Banu Arun
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|August 30, 2016
Handedness and breast cancer characteristicsKadri Altundag, Metin Isik, Ali R Sever
Nutrition and Cancer|September 15, 2022
Dietary Phytochemical Index and the Risk of Breast Cancer: A Case-Control StudyAylin Acikgoz Pinar, Emine Yildiz, Kadri Altundag
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Journal of Cancer Research and Therapeutics|October 12, 2019
Favorable results of patients with pT1a, b, c, lymph node-negative early breast cancer in the long intervalNilufer Bulut, Arife Ulas, Kadri Altundag
Expert Opinion on Pharmacotherapy|March 30, 2010
Systemic treatment in breast-cancer patients with brain metastasisCagatay Arslan, Omer Dizdar, Kadri Altundag
Expert Opinion on Pharmacotherapy|October 21, 2015
Advances in PARP inhibitors for the treatment of breast cancerOmer Dizdar, Cagatay Arslan, Kadri Altundag
Expert Opinion on Pharmacotherapy|July 18, 2014
Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an updateCagatay Arslan, Omer Dizdar, Kadri Altundag
Expert Opinion on Pharmacotherapy|October 28, 2010
The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectivesOnder Tonyali, Cagatay Arslan, Kadri Altundag
Expert Opinion on Pharmacotherapy|July 31, 2009
Pharmacotherapy of triple-negative breast cancerCagatay Arslan, Omer Dizdar, Kadri Altundag
Medical Oncology (Northwood, London, England)|April 23, 2013
The significance of heat shock proteins in breast cancer therapySevil Oskay Halacli, Burcin Halacli, Kadri Altundag
Current Medicinal Chemistry. Anti-Cancer Agents|March 22, 2005
Monoclonal antibody-based targeted therapy in breast cancerKadri Altundag, Francisco J Esteva, Banu Arun
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|August 30, 2016
Handedness and breast cancer characteristicsKadri Altundag, Metin Isik, Ali R Sever
Nutrition and Cancer|September 15, 2022
Dietary Phytochemical Index and the Risk of Breast Cancer: A Case-Control StudyAylin Acikgoz Pinar, Emine Yildiz, Kadri Altundag
Pageof 16